S.V. BATYRSHINA

Kazan State Medical University, 11 Butlerov St., Kazan, Russian Federation, 420012

Batyrshina S.V. — D. Med. Sc., Professor of the Department of Dermatovenerology, tel. (843) 236-99-92, e-mail: sbkdv@mail. ru

The article presents the characteristics of age-related skin changes. Main theories of aging and the most likely causes of violation of the structural integrity and functional capabilities of the skin are described. There were identified structural units (target) of the skin, at which happens realization of the aging process. The opportunities for conservation and restoration of the quality characteristics of the skin in women are presented. The influence of endogenous estrogen on skin, estrogen deficiency with age-related changes of the skin and the possibility of hormone replacement therapy (HRT) are described.

Key words: age-related skin changes, hormonal replacement therapy.

REFERENCES

1. The Population Division Department of Economic and Social Affairs United Nations Secretariat The Ageing of the World’s Population, 2005, available at: www.un.org/esa/socdev/ageing/agewpop. htm
2. Punnonen R., Lovgren T., Kouvonen I. Demonstration of estrogen receptors in the skin. J Endocrinol. Invest., 1980, vol. 3, pp. 217-221.
3. Hall G., Phillips T. J. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J. Am. Acad Dermatol., 2005, vol. 53, pp. 558-568.
4. Muramatsu M., Inoue S. Estrogen receptors: how do they control reproductive and non-reproductive functions? Biochem. Biophys. Res. Commun., 2000, vol. 270, pp. 1-10.
5. Speroff L. A clinical understanding of the estrogen receptor. Ann. N. Y. Acad. Sci., 2000, vol. 900, pp. 26-39.
6. Schmidt J. B., Lindmaier A., Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol. Obstet. Invest., 1990, vol. 30, pp. 97-100.
7. Thornton M.J., Taylor A.H., Mulligan K., Al-Azzawi F., Lyon C.C., O’Driscoll J., Messenger A.G. The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit. J. Invest. Dermatol. Symp. Proc., 2003, vol. 8, pp. 100-103.
8. Punnonen R. On the effect of castration and peroral estrogen therapy on the skin. Acta. Obstet. Gynecol. Scand., 1971, vol. 9 (Suppl. 9), pp. 32-36.
9. Rauramo L., Punnonen R. Effect of oral ostrogentherapie with ostriolsuccinat on the skin of castrated women. Z. Haut. Geschl. Kr., 1969, vol. 44, pp. 463-470.
10. Kanda N., Watanabe S. 17β-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. J. Invest. Dermatol., 2003, vol. 121, pp. 1500-1509.
11. Shah M.G., Maibach H.I. Estrogen and skin. An overview. Am. J. Clin. Dermatol., 2003, vol. 2 (3), pp. 143-150.
12. Raine-Fenning N. J., Brincat M. P., Muscat-Baron Y. Skin aging and menopause; implications for treatment. Am. J. Clin. Dermatol., 2003, vol. 4, pp. 371-378.
13. Sator P. G., Schmidt J. B., Sator M. O., Huber J. C., Hönigsmann H. The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas, 2001, vol. 39 (1), pp. 43-55.
14. Callens A., Valliant L., Lecomte P. et al. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology, 1996, vol. 193, pp. 289-294.
15. Shah M. G., Maibach H. I. Estrogen and skin. An overview. Am. J. Clin. Dermatol., 2003,vol. 2 (3), pp. 143-50.
16. Brincat M. P., Baron Y. M., Galea R. Estrogens and the skin. Climacteric, 2005, vol. 8 (2), pp. 110-123.
17. Neder L., Medeiros S. F. Topical estradiol does not interfere with the expression of the metalloproteinase-1 enzyme in photo exposed skin cells. An. Bras. Dermatol., 2012, vol. 87 (1), pp. 70-75.
18. Emmerson E., Hardman M.J. The role of estrogen deficiency in skin ageing and wound healing. Biogerontology, 2012, vol. 13 (1), pp. 3-20.
19. Stevenson S., Thornton J. Effect of estrogens on skin aging and the potential role of SERMs. Clin. Interv. Aging, 2007, vol. 2 (3), pp. 283-97.
20. Pierard G. E., Hermanns-L. T., Gaspard U., Piérard-Franchimont C. Asymmetric facial skin viscoelasticity during climacteric aging. Clin. Cosmet. Investig. Dermatol., 2014, vol. 7, pp. 111-118.
21. Lemperle G., Holmes R. E., Cohen S. R., Lemperle S. M. A classification of facial wrinkles. Plastic. Reconstructive Surg., 2001, vol. 108, pp. 1735-1750.
22. Pierard-Franchimont C., Conril F., Dehavay J., Deleixhe-Mauhin F., Letot B., Pierard G. E. Climacteric skin ageing of the face-a prospective longitudinal comparative trial on the effect of oral hormone replacement therapy. Maturitas, 1999, vol. 32, pp. 87-93.
23. Castelo-Branco C., Duran M., Gonzalez-Merlo J. Skin collagen changes related to age and hormone replacement therapy. Maturitas, 1992, vol. 15, pp. 113-119.
24. Maheuz R., Naud F., Rioux M., Grenier R. et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am. J. Obstet. Gynecol., 1994, vol. 170, pp. 642-649.
25. Callens A., Vaillant L., Lecomte P., Berson M., Gall Y., Loreete G. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology, 1996, vol. 193,pp. 289-294.
26. Falanga V., Bucalo B. Use of a durometer to assess skin hardness. J. Am. Acad. Dermatol., 1993, vol. 29, pp. 47-51.
27. Sator P. G., Schmidt J. B., Sator M. O., Huber J. C., Honigsmann H. The influence of hormone replacement therapy on skin ageing; a pilot study. Maturitas, 2001, vol. 39, pp. 43-55.
28. Dunn L. B., Damesyn M., Moore A. A., Reuben D. B., Greendale G. A. Does estrogen prevent skin ageing? Results from the first national health and nutrition examination survey (NHANES I). Arch. Dermatol., 1997, vol. 133, pp. 339-342.
29. Brincat M., Kabalan S., Studd J. W., Moniz C. F., de Trafford J., Montgomery J. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstet. Gynecol., 1987, vol. 70, pp. 840-845.
30. Savvas M., Bishop J., Laurent G., Watson N., Studd J. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br. J. Obstet. Gynaecol., 1993, vol. 100, pp. 154-156.
31. Shuster S., Black M., McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br. J. Dermatol., 1985, vol. 93, pp. 639-643.
32. Brincat M. P., Baron Y. M., Galea R. Estrogens and the skin. Climacteric, 2005, vol. 8, pp. 110-123.
33. Pelletier G., Ren L. Localization of sex steroid receptors in human skin. Histol. Histopathol., 2004, vol. 19 (2), pp. 629-636.
34. Schmidt J. B., Binder M. et al. Treatment ofskin ageing symptoms in perimenopausal femaleswith estrogen components. A pilotstudy. Maturitas, 1994, vol. 20, pp. 25-30.
35. Sator P. G., Schmidt J. B., Sator M. O., Huber J. C., Hönigsmann H. The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas, 2001, vol. 39 (1), pp. 43-55.
36. Schmidt J. B., Binder M. Treatment ofskin ageing symptoms in perimenopausal femaleswith estrogen components. A pilotstudy. Maturitas, 1994, vol. 20, pp. 25-30.
37. Sator P. G. Skin treatments and dermatological procedures to promote youthful skin. Clin. Interv. Aging, 2006, vol. 1 (1), pp. 51-63.
38. Zaydieva Ya. Z., Mirzoeva P. N. Regression main symptoms of aging skin after 3 months of therapy with Femoston 1/10 and 1/5 Femoston continent. Voprosy ginekologii, akusherstva i perinatologii, 2008, no. 2, pp. 31-36 (in Russ.).
39. Sator P.G., Sator M.O., Schmidt J.B., Nahavandi H., Radakovic S., Huber J.C., Honigsmann H. A prospective, randomized, placebo-controlled study of the effect of hormone replacement therapy on skin aging in postmenopausal women. Climacteric, 2007, vol. 10, pp. 320-334.
40. Franko O. H. Changing course in aging research: The Healthy Aging Phenotype. Maturitas, 2009, vol. 63, pp. 13-19.